控制哺乳动物细胞正常功能的生理过程受到无数信号通路的调节。哺乳动物丝裂原活化蛋白(MAP)激酶构成主要的信号传导臂之一,并已大致分为四类,包括细胞外信号调节蛋白激酶(ERK),c-Jun氨基末端激酶(JNK),p38和ERK5。每个信号级联由广泛的外部和细胞刺激控制,它们在哺乳动物细胞中对各种关键反应的调节中起着至关重要的作用,如促有丝分裂生长,分化,应激反应,以及炎症。这种进化保守的MAP激酶信号传导臂对于代谢维持也很重要。通过复杂的机制紧密协调,包括支架蛋白的复杂相互作用,通过同源基序识别,磷酸酶的作用,不同的亚细胞定位,甚至翻译后修饰。信号通路本身或其调节的畸变与代谢稳态的破坏有关,为代谢综合征的发生发展提供了病理生理学基础。代谢综合征是一个总称,通常包括一组密切相关的代谢性疾病,如高血糖症,高脂血症,和高血压。这些危险因素加剧了肥胖的发展,糖尿病,动脉粥样硬化,心血管疾病,和肝脏疾病,这导致了全球发病率和死亡率的上升。这篇综述旨在总结最近的发现,这些发现涉及MAP激酶信号传导在代谢性疾病的发展中。强调了该途径的潜在治疗靶标,有待进一步研究以减轻这些疾病。
Physiological processes that govern the normal functioning of mammalian cells are regulated by a myriad of
signalling pathways. Mammalian mitogen-activated protein (MAP) kinases constitute one of the major
signalling arms and have been broadly classified into four groups that include extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), p38, and ERK5. Each
signalling cascade is governed by a wide array of external and cellular stimuli, which play a critical part in mammalian cells in the regulation of various key responses, such as mitogenic growth, differentiation, stress responses, as well as inflammation. This evolutionarily conserved MAP kinase
signalling arm is also important for metabolic maintenance, which is tightly coordinated via complicated mechanisms that include the intricate interaction of scaffold proteins, recognition through cognate motifs, action of phosphatases, distinct subcellular localisation, and even post-translational modifications. Aberration in the
signalling pathway itself or their regulation has been implicated in the disruption of metabolic homeostasis, which provides a pathophysiological foundation in the development of metabolic syndrome. Metabolic syndrome is an umbrella term that usually includes a group of closely associated metabolic diseases such as hyperglycaemia, hyperlipidaemia, and hypertension. These risk factors exacerbate the development of obesity, diabetes, atherosclerosis, cardiovascular diseases, and hepatic diseases, which have accounted for an increase in the worldwide morbidity and mortality rate. This review aims to summarise recent findings that have implicated MAP kinase signalling in the development of metabolic diseases, highlighting the potential therapeutic targets of this pathway to be investigated further for the attenuation of these diseases.